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The interaction of the Listeria monocytogenes (Lm) 
surface protein InlA with its receptor E-cadherin 
(Ecad),  expressed  by  intestinal  epithelial  cells 
(IECs), is critical for the translocation of this 
human foodborne pathogen across the intestinal 
barrier and the onset of a systemic infection 
(Lecuit et al., 2001). InlA interaction with Ecad 
is species specific: human Ecad (hEcad) is a re-
ceptor for InlA, whereas mouse Ecad (mEcad) is 
not (Lecuit et al., 1999). We have shown that in 
hosts permissive to InlA–Ecad interaction, such 
as transgenic mice expressing hEcad and knockin 
mice expressing humanized mEcad, Lm directly 
invades enterocytes and crosses the intestinal epi-
thelium (Lecuit et al., 2001; Disson et al., 2008). 
However, Ecad is an adherens junction protein 
typically located below tight junctions (TJs) and 
is therefore thought to be inaccessible to bacteria 
located in the intestinal lumen (Boller et al., 1985; 
Sousa et al., 2005). Lm has been reported to   
invade the tip of intestinal villi at sites of cell ex-
trusion (Pentecost et al., 2006, 2010). An in vitro 
study in cultured epithelial kidney cells (MDCK 
cells) has shown that cell extrusion is associated 
with junction remodeling that transiently ex-
poses Ecad on extruding cells and their immedi-
ate neighbors (Pentecost et al., 2006), and in vivo 
studies have confirmed that this process is ac-
companied by redistribution of apical junctional 
complex proteins (Madara, 1990; Marchiando   
et al., 2011). Nevertheless, apart from intestinal 
villus tips, the sites of Lm adhesion to and trans-
location across the intestinal epithelium in vivo 
have not been investigated systematically, and 
the molecular mechanisms that lead to Lm actual 
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Listeria monocytogenes (Lm) is a foodborne pathogen that crosses the intestinal barrier 
upon interaction between its surface protein InlA and its species-specific host receptor  
E-cadherin (Ecad). Ecad, the key constituent of adherens junctions, is typically situated 
below tight junctions and therefore considered inaccessible from the intestinal lumen. In 
this study, we investigated how Lm specifically targets its receptor on intestinal villi and 
crosses the intestinal epithelium to disseminate systemically. We demonstrate that Ecad is 
luminally accessible around mucus-expelling goblet cells (GCs), around extruding entero-
cytes at the tip and lateral sides of villi, and in villus epithelial folds. We show that upon 
preferential adherence to accessible Ecad on GCs, Lm is internalized, rapidly transcytosed 
across the intestinal epithelium, and released in the lamina propria by exocytosis from 
where it disseminates systemically. Together, these results show that Lm exploits intrinsic 
tissue heterogeneity to access its receptor and reveal transcytosis as a novel and unantici-
pated pathway that is hijacked by Lm to breach the intestinal epithelium and cause  
systemic infection.
© 2011 Nikitas et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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intestinal epithelium into the lamina propria to cause sys-
temic infection. These results illustrate the critical importance 
of extending cellular microbiology to three-dimensional 
tissue systems to understand the pathophysiology of infec-
tious diseases.
RESULTS
Lm rapidly translocates across the intestinal epithelium
To study the early stages of Lm intestinal crossing, we inocu-
lated intestinal ligated loops of iFABP-hEcad transgenic mice, 
which express hEcad under the control of the iFABP pro-
moter (Lecuit et al., 2001), with Lm and imaged whole 
mount small intestinal tissue by two-photon and confocal 
microscopy.  Noninfected  small  intestinal  tissues  immuno-
labeled for hEcad display a typical epithelial honeycomb-like 
pattern (Fig. 1 A, Fig. S1 A, and Video 1). In infected intesti-
nal loops, as early as 30 min postinoculation (p.i.), bacteria 
were associated with intestinal villi (Fig. 1 B): we detected 
Lm adhering to the apical surface of enterocytes, within en-
terocytes, and at the basal pole of enterocytes. To our surprise 
given this early time point, we also detected Lm in the lamina 
propria (Fig. 1 C and Video 2). Because of the classical intra-
cellular cycle of Lm and its time frame in vitro, we would 
have anticipated that Lm intestinal translocation in the lamina 
propria would require at least 45 min to occur. We thus per-
formed a kinetic analysis of Lm invasion of the intestinal tis-
sue and studied the contribution of InlA to this process. Using 
two-photon and confocal imaging, we compared the associa-
tion of WT Lm to that of its inlA isogenic mutant with in-
testinal villi 5, 15, 30, and 45 min p.i. We observed a time- and 
InlA-dependent Lm association to intestinal villi (Fig. 1 D); as 
early as 15 min p.i., Lm was significantly associated with in-
testinal villi in a strict InlA-dependent manner. We further 
quantified bacteria located (a) on the villus surface, (b) in epi-
thelial cells, and (c) in the lamina propria, along the villus 
vertical axis 30 min p.i. We observed that most bacteria were 
40–80 µm away from the villus tip and were located in the 
lamina propria (Fig. 1 E). We conclude that Lm translocation 
across the intestinal barrier into the lamina propria is strictly 
InlA dependent, occurs all along the villus z axis, and is par-
ticularly rapid.
Ecad is accessible from the luminal side of the intestinal 
epithelium around GCs
Because Lm early translocation across the intestinal barrier is 
InlA–Ecad dependent and occurs along the z axis of intestinal 
villi, we investigated Ecad accessibility from the luminal side 
of uninfected intestinal epithelium of iFABP-hEcad trans-
genic mice. We first performed a double staining, in which 
luminally accessible hEcad was stained before tissue permea-
bilization and total hEcad was stained after tissue permeabili-
zation with HECD-1, an mAb raised against extracellular 
domain of hEcad that does not recognize mEcad (Fig. 2 A). 
Accessible hEcad was observed at the surface of junctional 
complexes as well as along the lateral sides of the cells (Fig. 2, 
A and B, insets; Fig. 3 A, B, and D; and Video 3). We next 
translocation across the intestinal epithelium and release into 
the lamina propria remain unknown.
In vitro studies have demonstrated that Lm enters into 
nonphagocytic cells within 10 min through a zippering pro-
cess (Mengaud et al., 1996; Cossart and Sansonetti, 2004). Upon 
internalization, the bacterium is entrapped in a membrane- 
bound  compartment,  from  which  it  is  able  to  escape   
within 10–15 min (Myers et al., 2003; Henry et al., 2006). 
Vacuolar escape is mediated by the pore-forming activity   
of the secreted cholesterol-dependent listeriolysin O (LLO; 
Garcia-del Portillo and Finlay, 1995; Cossart and Sansonetti, 
2004). Upon vacuolar lysis, Lm reaches the cytosol, in which 
it can polymerize host actin to form comet tails that propel 
bacteria intracellularly and form protrusions that allow Lm 
transfer into neighboring cells (see schematic representation 
in Fig. S6 A). This process is strictly dependent on the listerial 
surface protein ActA, which is necessary and sufficient on the 
bacterial side to mediate actin polymerization (Kocks et al., 
1992).  Actin  nucleation  around  bacteria  can  be  observed 
within 15 min after vacuolar escape, and  Lm-containing 
protrusions can be observed 2.5 h upon infection (Tilney 
et al., 1992).
The goal of our study was to determine comprehensively 
Lm intestinal epithelial target cells and to decipher the mech-
anisms  of  Lm  crossing  of  the  intestinal  epithelial  barrier   
in vivo. To identify Lm intestinal epithelial target cells, we first 
studied Ecad luminal accessibility by two-photon and con-
focal imaging of noninfected whole mount intestinal tissue of 
humanized transgenic mice permissive to InlA and investi-
gated the sites of InlA–Ecad-dependent bacterial association 
with the intestinal epithelium. We demonstrate that Ecad is 
luminally accessible at discrete locations, which are (a) junc-
tions between mucus-secreting goblet cells (GCs) and adja-
cent enterocytes, (b) extruding enterocytes at the tip of villi, 
as previously proposed by Pentecost et al. (2006, 2010), but 
also along their lateral sides, and (c) villus epithelial folds. We 
show that among GCs, those that have expelled their mucus 
content are those that typically exhibit luminally accessible 
junctional Ecad. Importantly, we identify GCs as the Lm 
preferential targets at the intestinal barrier level and establish 
a positive correlation between the number of GCs and the 
efficiency of Lm intestinal invasion and systemic dissemina-
tion. We further show that Lm translocation across the intes-
tinal epithelium into the lamina propria mostly occurs below 
intestinal villus tips, is very rapid and efficient, and is strictly 
InlA dependent, whereas LLO and ActA play no role in this 
process. Finally, we show that Lm is rapidly transcytosed in a 
vacuole in a microtubule-dependent manner across entero-
cytes and egresses from them by exocytosis. Lm rapid InlA–
Ecad-dependent  translocation  across  the  intestinal  barrier 
results in a similarly rapid bacterial systemic dissemination.
Transcytosis is a so far unsuspected infection strategy for 
Lm, which is critical for its rapid and efficient crossing of the 
intestinal epithelium upon targeting of its receptor Ecad. 
This study provides, to our knowledge, the first in vivo 
elucidation of how an enteropathogen translocates across the JEM Vol. 208, No. 11 
Article
2265
and WT C57BL/6 mice with ECCD2, an mAb raised against 
the extracellular domain of mEcad (Fig. S1, B and C), dem-
onstrating that Ecad accessibility does not result from hEcad 
transgenic expression.
We next determined the relative number of the IECs that 
express luminally accessible hEcad and found that 2% of 
total IECs fall into this category. To determine the cell sub-
types that express accessible hEcad, we costained intestinal 
villi for luminally accessible hEcad and wheat germ aggluti-
nin (WGA). WGA specifically binds 
to sialic acid and N-acetylglucosaminyl 
carbohydrate residues present on the 
plasma membrane of enterocytes and 
in mucus of GCs (Fischer et al., 1984; 
Jang et al., 2004). We observed that 
among enterocytes, which were WGA 
positive (WGA+), as expected, some 
expressed luminally accessible hEcad 
and were identified as either extruding 
apoptotic cells or cells located within 
intestinal epithelial folds (Fig. 2 B, 
arrow;  Fig.  S4,  A,  E,  and  I;  and   
Videos 3, 8, and 9). Importantly, we 
also identified isolated WGA–highly 
positive cells (WGAhi) expressing lu-
minally  accessible  hEcad  (Fig.  2  B,   
inset; Fig. 3, A, B, and D; Fig. S1 C; 
Fig.  S3  A;  and  Videos  3  and  4). 
These WGAhi cells exhibited a weaker   
investigated the precise location of accessible hEcad on villi. 
We observed that hEcad is luminally accessible at the tip of 
villi (Fig. 2 B, arrow; see other examples in Fig. S4 A, insets; 
and Video 3), as previously proposed (Pentecost et al., 2006). 
Importantly, we also detected luminally accessible hEcad at 
distinct spots along the longitudinal axis of intestinal villi 
(Fig. 2 B, insets; see other examples in Fig. S4, E and I, insets; 
and Video 3). Similar results were obtained when total   
and/or accessible endogenous mEcad was labeled in transgenic 
Figure 1.  Lm rapidly crosses the epithe-
lium of iFABP-hEcad transgenic mice in 
an InlA-dependent manner. (A) Intestinal 
tissue of iFABP-hEcad transgenic mice was 
fixed, permeabilized, and stained for F-actin 
and hEcad. A three-dimensional reconstruc-
tion of an intestinal villus is shown. (B) Three-
dimensional reconstruction of an intestinal 
villus of iFABP-hEcad transgenic mouse in-
fected with 109 Lm for 45 min and stained for 
hEcad and nuclei. (C) Optical sections and 
insets show Lm (asterisks) interacting with 
intestinal villus along its length (z in microm-
eters corresponds to distance from villus tip). 
Insets are a magnification of Lm (indicated by 
asterisks) interacting with intestinal villus 
epithelial cells or inside the lamina propria. 
Bars, 10 µm. (D) Quantification of Lm associ-
ated with intestinal villus (***, P < 0.001, as 
assessed by two-way analysis of variance and 
Tukey adjustment). Error bars indicate SD.  
n = 10 villi from three mice. (E, left) Longitu-
dinal section of a villus on which planes along 
its z axis are depicted. (right) Quantification of 
Lm localized on the villus surface, in epithelial 
cells, or in the lamina propria along the z axis 
of intestinal villi. n = 10 villi from three mice. 
Pictures are representative of three mice.2266 Listeria target mucus-producing goblet cells | Nikitas et al.
cells expressing accessible hEcad; in fact, up to one third of 
GCs (32%) express luminally accessible hEcad, whereas only 
a very small proportion (1%) of non-GCs do (Fig. 2 F). Ac-
cessible hEcad immunolabeling in the presence of Lm was 
similar to uninfected intestinal tissue (Fig. S2 D), indicating 
that hEcad luminal accessibility is not induced by Lm but 
rather reflects physiological tissue heterogeneity.
Ecad luminal accessibility on GCs correlates with cell 
junction reorganization and mucus secretion
Cell–cell junctions involving GCs have been described as 
heterogeneous  and  relatively  weaker  than  those  between 
classical enterocytes (Madara et al., 1980; Madara and Trier, 
1982). Moreover, cell shape changes that GCs undergo during 
mucus secretion have been associated with the loosening of 
their TJs (Hull and Staehelin, 1976; Porvaznik et al., 1983). 
cortical  actin  cytoskeleton  compared  with  WGA+  cells 
(Fig. S2 A, arrows) and were strongly immunolabeled with 
antibodies against Mucin 2 (Muc-2) and intestinal trefoil fac-
tor (ITF; Fig. S2, B and C), identifying them unambiguously 
as  GCs  (Poulsom  and  Wright,  1993;  van  Klinken  et  al., 
1999). We also observed that hEcad is enriched along the lat-
eral membranes of GCs compared with neighboring entero-
cytes (Fig. 3 D), whereas accessible hEcad was not detectable 
at the apical dome of GCs, where Ecad-negative mucin gran-
ules fuse with the apical membrane and exocytose their 
mucus content (Fig. 3, A, B, and D).
We next quantified the relative proportion of GCs and 
non-GCs that display luminally accessible Ecad: GCs repre-
sent 2.8% of the total IECs (Fig. 2, C and D) but account for 
half of the cells that exhibit accessible hEcad (Fig. 2 E), dem-
onstrating  a  significant  overrepresentation  of  GCs  among 
Figure 2.  Ecad is accessible from the luminal side of intestinal villi and is mainly detectable around GCs. (A) Intestinal tissue of iFABP-hEcad 
transgenic mice was fixed and stained for luminally accessible (acc) hEcad before tissue permeabilization, total hEcad, and nuclei after tissue permeabili-
zation. The image is an optical section of an intestinal villus. Right panels show separated channels and merge of boxed regions, showing accessible 
hEcad on the apical and lateral sides of cells. (B) Intestinal cells express luminally accessible hEcad. Stack projection of nonpermeabilized intestinal villi 
stained with WGA and for accessible hEcad and nuclei. The arrow shows a site of luminally accessible hEcad at the villus tip. Right panels show magnifi-
cation of the boxed region, which shows a GC surrounded by a ring of accessible hEcad at its apical pole. Pictures are representative of three mice. Bars, 
10 µm. (C) Schematic representation of an intestinal villus. (D) Quantification of cell subtypes in intestinal villi. GCs, 2.8%; non-GCs, 97.2%. n = 20 villi 
from two mice. (E) Quantification of cell subtypes expressing luminally accessible hEcad in intestinal villi. n = 20 villi from two mice. (F) Relative propor-
tion of cell types with accessible hEcad. n = 20 villi from two mice. (D–F) Error bars indicate SD.JEM Vol. 208, No. 11 
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studying the localization of two major TJ components, ZO-1 
and occludin. In GCs in which hEcad was accessible, both 
markers exhibited a pattern distinct from classical absorptive 
epithelial cells, with a thicker occludin signal (Fig. 3 B,   
Fig. S3 A, and Video 5) and either a thicker ZO-1 signal in cells 
that had expelled their mucus content (Fig. 3 B) or a fainter 
signal in cells full of mucus (Fig. S3 B). PKC and PAR-3, 
To determine whether mucus secretion might provide lumi-
nal access to hEcad, we quantified the amount of mucus-
expelling GCs that express luminally accessible hEcad. 87% 
of GCs that express luminally accessible hEcad were secreting 
or had secreted their mucus content (mucus-expelling GCs; 
Fig. 3 A). Because TJ disorganization might provide luminal 
access to hEcad, we investigated their integrity in GCs by 
Figure 3.  Mucus-expelling GCs exhibit TJ reorganization and delocalization of cell polarity markers and express luminally accessible Ecad. 
(A) Intestinal tissues were fixed and stained with WGA and for accessible (acc) hEcad and nuclei. Mucus-expelling and mucus-filled GCs expressing lumi-
nally accessible hEcad were quantified. Error bars indicate SD. n = 30 villi from three mice. (right) Stack projection of intestinal epithelium showing an 
accessible hEcad+ GC expelling its mucosal content (arrows; a) and an accessible hEcad GC full of mucus (b). White dashed lines outline the border of 
GCs. (B) Intestinal tissues were fixed and stained with WGA and for accessible hEcad and TJ proteins (red). (top) Accessible hEcad of a GC (arrows) colocal-
izes with thickened TJ protein occludin. (bottom) TJ protein ZO-1 is thickened on the apical side of a GC (arrows) with accessible hEcad. (C, top) PAR-3 is 
depolarized around mucus-expelling GCs (asterisks). (bottom) PKC is delocalized from the apical region on mucus-expelling GCs (asterisks). (B and C) Stack 
projections of whole mount tissues are shown. (D) Intestinal tissues were fixed and stained with WGA and for accessible hEcad, total hEcad, and nuclei. 
(top) A GC (asterisks) presents an enrichment of total hEcad along its lateral membranes. (bottom) XZ and YZ sections at selected position. Pictures  
are representative of three mice. Bars, 10 µm.2268 Listeria target mucus-producing goblet cells | Nikitas et al.
In addition, the InlA–Ecad interaction provides a >15-fold Lm 
preference for GCs compared with the inlA mutant, which 
demonstrated no cellular preference (Fig. 4 C, right). Finally, 
WT Lm relative associations per NGC were as low as with 
AGCs. Overall, these results demonstrate that Lm preferentially 
together with PAR-6, are known to localize at epithelial 
junctional complexes and have been implicated in the re-
cruitment of junction proteins at the cell–cell interface and in 
the establishment and maintenance of cell polarity in Dro-
sophila melanogaster and mammalian epithelial cells (Izumi   
et al., 1998; Ohno, 2001; Hirose et al., 2002). As expected, 
we  observed  that  PAR-3  and  PKC  were  recruited  at 
junctional complexes of absorptive epithelial cells (Fig. 3 C;   
Fig. S3, C and D; and Videos 6 and 7). In contrast, in GCs, 
we observed a striking depolarization of PAR-3, which was 
detectable all along GCs (Fig. 3 C, asterisks; Fig. S3 C; and 
Video 6), as well as a disappearance of PKC accumulation at 
junctional complexes (Fig. 3 C, Fig. S3 D, and Video 7).
Together, these results indicate that TJs of GCs are disorga-
nized compared with classical TJs on absorptive cells. These 
structural features of GCs, together with the extensive cell shape 
changes occurring during mucus secretion, likely account for 
luminal accessibility of Ecad in mucus-expelling GCs.
As with GCs, non-GCs expressing luminally accessible 
hEcad exhibited a relative redistribution of TJ proteins and 
cortical actin network when stained for occludin, ZO-1,   
and PKC (Fig. S4, B–D, F–H, and J–L; and Table S1) and   
F-actin (Fig. S4 M), respectively. These observations fit with 
a redistribution of apical junctional complex proteins and an 
enrichment of Ecad during apoptotic cell shedding at the tip 
of intestinal villi, as previously shown (Fig. S4, A–H, and N; 
and Video 8; Marchiando et al., 2011), and with a relative 
exacerbated tension exerted on cell–cell junctions within   
villus epithelial folds (Fig. S4, I–L; and Video 9).
Lm preferentially targets intestinal GCs expressing  
luminally accessible Ecad
Having identified GCs as strongly overrepresented among cells 
expressing luminally accessible Ecad (Fig. 2 F), we next investi-
gated Lm preferential cell targets at the intestinal level. To this 
end, we distinguished three cell categories: (a) GCs, (b) cells next 
to GCs (NGCs; i.e., cells forming junctions with GCs), and   
(c) cells away from GCs (AGCs; i.e., all other IECs; Fig. 4 A).
The relative proportions of GCs, NGCs, and AGCs to   
total IECs per villus were 2.8%, 8.5%, and 89.5%, respectively 
(Fig. 4 B). To assess whether Lm preferentially targets one cell 
subtype and to investigate the importance of accessible hEcad 
in Lm association and subsequent translocation, we evaluated 
the number of WT Lm that were associated with each of these 
three cell categories, in conjunction with the presence of ac-
cessible hEcad on these cells and in comparison with the inlA 
Lm isogenic mutant. 40 min p.i., we observed that Lm adhered 
to each of these three cell categories expressing accessible 
hEcad (Fig. 4 A, top) and that Lm was translocated from the 
apical to the basal pole of these three cell categories (Fig. 4 A, 
middle and bottom). We then determined the preference of 
Lm for each cell type by calculating the number of Lm per cell, 
relative to the respective abundance of each cell type (see Mate-
rials and methods). We show that although GCs represent a very 
low proportion of intestinal cells (2.8%; Fig. 4 B), WT Lm inter-
acts >20 times more with GCs than with AGCs (Fig. 4 C, left). 
Figure 4.  Lm interacts preferentially with GCs at sites where 
hEcad is luminally accessible and transits toward the lamina  
propria. (A) The intestinal loop of iFABP-hEcad transgenic mice was in-
fected with 3 × 109 Lm for 40 min. The intestinal tissue was fixed and 
stained with WGA and for hEcad and nuclei. Optical sections of intestinal 
mucosa show Lm interacting in and entering an IEC away from (left), next 
to (middle), and in (right) GCs at sites where hEcad is luminally accessible 
(top). (middle) Lm in an IEC. (bottom) Lm exits IECs at their basolateral 
side. Dashed lines indicate basal membrane separating the intestinal epi-
thelium from the lamina propria. Pictures are representative of three 
mice. Bar, 10 µm. (B) Quantification of cell subtypes per villus. n = 30 villi 
from three mice. (C) Relative infection per cell type: number of Lm WT 
(left) and inlA (right) associated with the different cell subtypes express-
ing or not luminally accessible (acc) hEcad 30 min after infection has been 
calculated and AGC Lm WT set to 1. n = 12 villi from two mice.JEM Vol. 208, No. 11 
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targets accessible Ecad-expressing GCs on the epithelium of 
intestinal villi.
To further reinforce the critical role of GCs in Lm cross-
ing of the intestinal barrier, we next investigated how varia-
tion in the number of GCs would influence Lm intestinal 
tissue invasion and systemic dissemination. We treated hEcad 
transgenic mice with IL-33, which is well characterized as 
inducing an increase in the number of GCs and mucus se-
cretion (Moro et al., 2010; Neill et al., 2010). As expected, 
IL-33–treated mice exhibited an increase in the number of GCs 
per villus, as well as an increase in the amount of mucus pro-
duced (Fig. 5, A and C). Strikingly, this increase in GCs cor-
related  with  an  increase  in  Lm  invasion  of  intestinal  villi   
(Fig. 5, B and C) and systemic dissemination to the spleen 
(Fig. 5 D). Increased intestinal invasion was not observed with 
the inlA mutant (Fig. 5 B). Together, these results highlight 
a positive correlation between the number of GCs and Lm 
intestinal tissue invasiveness and systemic dissemination.
Lm does not need to access the host cell cytosol  
and polymerize actin to be translocated across  
the intestinal barrier
Having identified how and where Lm interacts with the intesti-
nal barrier in vivo and shown that its transfer into the lamina 
propria is particularly rapid, we next investigated the molecular 
mechanisms underlying Lm transepithelial translocation. We in-
fected intestinal loops of hEcad transgenic mice with 109 Lm or 
an isogenic inlA mutant, a hly mutant (not expressing LLO), 
a actA mutant, a nonpathogenic and noninvasive Listeria   
innocua (Li), or Li-expressing InlA (Li(inlA)). We quantified the 
amount of bacteria located in the intestinal lamina propria   
30 min upon infection. We observed no translocation to the in-
testinal lamina propria with the inlA deletion mutant or, as ex-
pected, with the noninvasive Li (Fig. 6 A). In contrast, Li(inlA) 
translocated rapidly into the lamina propria in equal numbers to 
Lm (Fig. 6 A). Strikingly, the hly and actA deletion mutants 
were able to invade and cross the intestinal epithelium as effi-
ciently as WT Lm. This demonstrates that the rapid translocation 
of Lm across the intestinal barrier is strictly dependent on the 
InlA–Ecad interaction, whereas the major virulence factors LLO 
and ActA are not required (Fig. 6 A), showing that the classical 
Figure 5.  Positive correlation between the number of GCs and the 
efficiency of Lm intestinal invasion and systemic dissemination.  
IL-33 or PBS alone was administered daily intraperitoneally to iFABP-hEcad 
transgenic mice for 3 d. Imaging and bacterial inoculation were per-
formed on day 3. (A) Optical section of intestinal villus stained with WGA 
and for F-actin. Intestinal villi of IL-33–treated mice (bottom) exhibit far 
more GCs, and GCs secrete far more mucus than PBS-treated control 
mice (top). (B) Inoculation of intestinal ligated loop were performed on 
day 3 with 3 × 109 of the indicated strain for 45 min. Panels show optical 
section of intestinal villus after a ligated loop infection of PBS-treated 
mouse with Lm WT, IL-33–treated mouse with Lm WT, or IL-33–treated 
mouse with Lm inlA. Infected intestinal villi were stained for F-actin, 
nucleus, and Lm (boxes and insets). (A and B) 250-µm vibratome sections 
are shown. Pictures are representative of two mice. Bars, 10 µm. (C) Quanti-
fication of GCs and internalized Lm in intestinal villus of PBS- or IL-33–
treated mice after a ligated loop infection of 45 min with 3 × 109 Lm. For 
each intestinal villus, GCs were enumerated on the larger longitudinal 
section of observed villi. Error bars indicate SD. n = 20 villi from two mice. 
(D) Quantification of Lm in the spleen after a ligated loop infection of  
45 min in PBS- or IL-33–treated mice on day 3. Horizontal bars indicate 
the mean. n = 4 mice (**, P < 0.01, as assessed by Student’s t test).
 2270 Listeria target mucus-producing goblet cells | Nikitas et al.
and rapid microtubule depolymerization (De Brabander et al., 
1976; Lee et al., 1980; Ravelli et al., 2004). Intestinal ligated 
loops were infected with 109 Lm for 10 min. Nocodazole or 
colchicine was then added and left in contact with the bacteria 
for 50 min. In nocodazole- as well as in colchicine-treated 
tissues, Lm resided within IECs (Fig. 6, C and D). Under these 
experimental conditions, Lm internalization into enterocytes 
was not affected, and the integrity of adherens junctions and 
TJs was preserved (Fig. S5 A). Yet microtubule depolymeriza-
tion inhibited Lm translocation across the intestinal epithelium. 
In  fact,  in  nocodazole-  and  colchicine-treated  loops,  the 
amount of bacteria associated with enterocytes was four times 
higher than in untreated loops (Fig. 6 C). In contrast, taxol, 
which inhibits disassembly of microtubules and stabilizes the 
microtubule network (Schiff and Horwitz, 1980), did not re-
duce Lm rapid translocation (unpublished data).
To investigate the role of vesicle fusion machinery in Lm 
release from its vacuole into the lamina propria, we investi-
gated the contribution of N-ethylmaleimide–sensitive factor 
(NSF) during infection of intestinal   
ligated loops. We used a fusion poly-
peptide (TAT-NSF700), composed  of 
an  HIV  transactivating  regulatory 
cell infection cycle of Lm is not at play in this process (Fig. S6 A). 
Furthermore, as early as 30 min p.i., Lm disseminated into deeper 
organs, such as the spleen (Fig. 6 B), in an InlA-dependent but 
LLO- and ActA-independent manner (Fig. 6 B), clearly demon-
strating the significance of the InlA-dependent but LLO- and 
ActA-independent rapid intestinal translocation for the onset of 
systemic listeriosis.
Lm transcytoses across IECs and exocytoses  
at their basal pole
The demonstration that LLO and ActA are dispensable for   
Lm translocation across the intestinal epithelium led us to for-
mulate the hypothesis of a rapid apicobasal transcytosis of   
Lm-containing vacuole and the exocytosis of Lm at the basal 
pole of enterocytes in the lamina propria. We first investigated 
the role of a critical component of the transcytosis machinery, 
the microtubule network, in Lm translocation across the intesti-
nal barrier using nocodazole, which prevents microtubule poly-
merization, and colchicine, which leads to dynamic instability 
Figure 6.  Lm translocates through IECs in 
an InlA-dependent but LLO- and ActA-
independent manner. (A) Intestinal loops 
were infected with 109 of the indicated Listeria 
strains, and bacteria were quantified in the 
lamina propria after 30 min. n = 30 villi from 
three mice. (B) Intestinal loops were infected 
with the indicated Listeria strains, and bacteria 
were quantified in the spleen after 30 min of 
infection. n = 5 mice. (C) Quantification of Lm 
located in IECs in tissue treated with 10 µg/ml 
nocodazole, 10 µg/ml colchicine, or their cor-
responding vehicles (control) for 50 min out of 
60 min of Lm infection. n = 11, 15, and 14 
infected villi from three mice, respectively.  
(D) Optical sections of Lm-infected villus treated 
with PBS as a control, nocodazole, or colchicine 
for 50 min out of 60 min of Lm infection. Arrows 
points to Lm either inside epithelial cells or  
in the lamina propria. (E) Quantification of  
Lm located in intestinal epithelium or in the 
lamina propria of tissue treated with PBS (con-
trol), 20 µg/ml TAT-NSF700, or 20 µg/ml TAT-
NSF scr for 30 min and during Lm infection for 
45 min. n = 20 infected villi from three mice. 
(A–C and E) Error bars indicate SD. (F) Optical 
sections of intestinal villus treated with PBS as 
a control, TAT-NSF peptide, or TAT-NSF scr for 
30 min and infected with Lm (arrows) in  
the presence of the peptides for 45 min.  
(D and F) Tissues are stained for F-actin. Pictures 
are representative of three mice. (G) TEM sections 
of PBS-, TAT-NSF700–, or TAT-NSF700scr–treated 
tissues. Pictures are representative of two mice. 
Bars: (D and F) 10 µm; (G) 2 µm.JEM Vol. 208, No. 11 
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TAT-NSF700 peptide conjugated to cyanin 3 (Fig. S5 B). 
This treatment led to an intracytosolic accumulation of vesi-
cles, which is consistent with the inhibition of the fusion ma-
chinery by TAT-NSF in enterocytes (Fig. 6 G). We then 
injected into the loops 109 Lm in the presence of each of the 
synthetic  peptides.  By  two-photon  microscopy  of  whole 
mount tissue, we determined and quantified Lm association 
with the epithelial sheet and its translocation into the lamina 
propria 45 min p.i. In TAT-NSF700–treated tissue, Lm trans-
location into the lamina propria was strongly inhibited, and 
bacteria remained within enterocytes, 
at the level of their basal pole. In un-
treated loops and in loops treated with 
TAT-NSF700scr,  bacteria  were  seen 
both in the lamina propria and within 
enterocytes (Fig. 6, E and F). Impor-
tantly, entry of Lm was not affected by 
TAT-NSF700 treatment because total 
Lm number per villus was not signifi-
cantly different in PBS-, TAT-NSF700–,   
or TAT-NSF700scr–treated tissue. Fi-
nally, by using transmission electron 
microscopy (TEM), we observed Lm 
enclosed in a vacuole below the cell 
nucleus of an IEC and in the vicinity 
of its basal pole in a TAT-NSF–treated 
tissue (Fig. 7 C). Together, these results 
peptide derived from the TAT protein domain fused to a 
peptide derived from the D2 domain of NSF, which binds 
ATP and regulates NSF hexamerization. TAT-NSF700 has 
been shown to cross cellular membranes, inhibit NSF hydro-
lysis of ATP, decrease NSF disassembly of SNARE mole-
cules, and disrupt vacuolar trafficking including exocytosis 
(Matsushita et al., 2005; Jahn and Scheller, 2006). We pre-
treated intestinal ligated loops with TAT-NSF700 or with a 
control peptide, TAT-NSF700scr, for 30 min. Entry of TAT-
NSF700 peptide in intestinal epithelium was verified using a 
Figure 7.  Lm-containing vacuole transfer 
across the intestinal barrier. (A) Intestinal 
tissue of iFABP-hEcad transgenic mice was 
infected with 109 Lm for 45 min, fixed, and 
stained for F-actin, Ecad cytoplasmic domain 
(cyto dom), and Lm. XZ and YZ show sections 
at selected positions. (B) Optical sections of 
infected intestinal villi of mtd Tomato mouse 
stained for Lm and nuclei and with WGA.  
(a) Lm (arrowheads) interacting with and en-
tering an enterocyte. (b and c) Lm (arrowheads, 
insets) inside an enterocyte and associated 
with membrane (red). (d) Lm (open arrowheads, 
bottom insets) in the lamina propria and not 
associated with membrane and another Lm 
(closed arrowheads, top insets) inside an en-
terocyte and associated with membrane (red). 
(C) TEM sections of TAT-NSF–treated and  
45-min Lm-inoculated ligated loop. (left) Intra-
cellular Lm located below the cell nucleus and 
close to the cell membrane (dashed black line) 
of an IEC. (top right) Higher magnification of 
main panel. Intracytosolic Lm is located close 
to the basal cell membrane (dashed black line). 
(bottom right) Higher magnification of top 
right panel (boxed area). Intracytosolic Lm is 
enclosed in a membrane vacuole. Pictures are 
representative of two mice. Bars: (A and B)  
10 µm; (C, left) 5 µm; (C, top right) 2 µm;  
(C, bottom right) 200 nm.2272 Listeria target mucus-producing goblet cells | Nikitas et al.
enclosed in a vacuole. This translocation is microtubule de-
pendent but independent of the virulence factors LLO and 
ActA. Furthermore, the exocytic machinery is involved in 
Lm release in the lamina propria. Finally, Lm rapid trans-
epithelial transcytosis leads to a similarly rapid systemic dis-
semination. Together, these results demonstrate that Lm is 
transcytosed across the intestinal epithelium (Fig. S6 B), thus 
revealing a novel and unsuspected pathway hijacked by Lm 
that is crucial for its rapid dissemination within the host.
We have identified novel in vivo sites of accessible Ecad 
around GCs, at cell–cell junctions with their neighbors, and 
along villus epithelial folds. Moreover, as previously reported 
in vitro (Pentecost et al., 2006, 2010), we found that Ecad is 
luminally accessible at cell extrusion sites. In a similar fashion 
as extruding cells, mucus-producing GCs undergo extensive 
shape changes such as stretch and compression during mucus 
secretion. These shape changes are accompanied with junc-
tional reorganization, notably variations in length and strand 
cross-linking and discontinuities (Hull and Staehelin, 1976; 
Madara  and  Trier,  1982;  Porvaznik  et  al.,  1983;  Madara, 
1990). Accordingly, we demonstrate here that TJs are dis-
organized between cells on which Ecad is luminally exposed 
and establish a correlation between mucus secretion and lu-
minal access to Ecad. Furthermore, cortical actin at the apex 
of GCs is greatly reduced compared with IECs (Oliver and 
Specian,  1990).  We  indeed  observed  a  reorganized  apical   
actin network at sites with accessible Ecad (Fig. S4 M), a result 
which is consistent with the well-established importance of 
the actin cytoskeleton in maintaining cell junction integrity 
by stabilizing Ecad clusters (Hagen and Trier, 1988; Cavey   
et al., 2008; Schill and Anderson, 2009). Finally, we also show 
that Ecad is luminally accessible in villus intestinal folds 
(Fig. S4 I and Video 9). The forces of tension and constric-
tion generated at these sites induce cell shape changes that 
may account for the relocation of Ecad to the apical luminal 
side, as previously described for adherens junction protein 
remodeling occurring during Drosophila gastrulation and ven-
tral furrow formation (Dawes-Hoang et al., 2005; Kölsch   
et al., 2007). Altogether, our investigations point to a cor-
relation between physical tensions, localization of adherens 
junction components and TJ remodeling at the intestinal epi-
thelium level. Lm targeting of accessible Ecad illustrates how 
a microbial pathogen can take advantage of tissue dynamics 
and heterogeneity in vivo, a facet of microbial pathogenesis 
which cannot be investigated in vitro in more static and   
homogenous systems.
We have demonstrated Lm preferential targeting of GC 
accessible Ecad and a correlation between GC numbers and 
Lm intestinal invasion and systemic dissemination. Even 
though mucus secretion is at the front line of the innate host 
defense in the gastrointestinal tract, Lm seems to exploit this 
innate defense mechanism by binding in an InlA-dependent 
manner to GCs. Moreover, although GCs are specialized in 
basal-apical transport, they also possess an endocytic and api-
cobasal transcytosis activity that Lm may hijack (Colony and 
Specian, 1987). Thus, Lm takes advantage of an intestinal   
show that disruption of vacuolar trafficking including exo-
cytosis impairs Lm translocation into the lamina propria.
We next attempted to colocalize translocating Lm with its 
surrounding membrane vacuole. We first used an antibody 
raised against the cytoplasmic domain of Ecad, which is ex-
pected to decorate the cytoplasmic side of Lm-containing 
vacuole. We observed Lm colocalizing with the cytoplasmic 
domain of Ecad (Fig. 7 A). To directly visualize vacuolar 
membrane around Lm, we crossed our mice expressing 
humanized Ecad with a transgenic mouse line expressing a 
membrane-targeted Tomato protein (mtd Tomato), in which 
all membranes are constitutively fluorescently labeled in red 
(Disson et al., 2008; Muzumdar et al., 2007). Infection of 
hEcad × mtd Tomato mice allowed the visualization of red 
membranes surrounding Lm during its apicobasal transloca-
tion, whereas Lm was no longer associated with a red signal 
once released in lamina propria (Fig. 7 B). These data con-
firm that Lm is transferred in the lamina propria in a mem-
brane-bound vacuole. Collectively, these results show that 
Lm is transferred apicobasally in a microtubule-dependent 
manner, is enclosed in a membrane-bound vacuole, and 
egresses the cell by exocytosis. This process can thus be re-
ferred to as transcytosis.
DISCUSSION
Microbial crossing of host barriers is a critical step of invasive 
infections. Understanding how microbes cross the intestinal 
barrier is thus key to comprehend the pathophysiology of 
foodborne  infections.  Lm  is  a  model  microorganism  for 
which a great deal of knowledge has been obtained by com-
bining in vitro and in vivo approaches. Yet how this food-
borne  pathogen  actually  crosses  the  intestinal  barrier  has 
remained elusive. Pentecost et al. (2006, 2010) have reported 
that Lm targets intestinal villus tips to invade the epithelium 
at sites of cell extrusion and, based on in vitro observation 
obtained in cultured kidney epithelial cells, proposed that 
these were sites of accessible Ecad. Nevertheless, the exis-
tence of other sites of intestinal translocation as well as the 
precise molecular mechanism by which Lm is actually trans-
ferred across the intestinal barrier monolayer have so far not 
been addressed. This prompted us to set up an experimental 
approach based on the comprehensive imaging of uninfected 
and  infected  intestinal  tissues  of  iFABP-hEcad  transgenic 
mice. This approach preserves the intrinsic cell heterogeneity 
in a tissue context, allowing us to perform a detailed study of 
the initial steps of Lm invasion and of the mechanisms   
of translocation across the intestinal epithelium with a level of 
scrutiny usually reserved for cultured cells. We demonstrate 
that Ecad is luminally accessible at cell–cell junctions between 
mucus-expelling GCs and adjacent enterocytes all along the 
vertical axis of intestinal villi. We show that Lm accesses the 
intestinal lamina propria mostly all along the villus longitudi-
nal axis and mainly targets luminally accessible Ecad of GCs 
to adhere to and invade the intestinal epithelium in an InlA-
dependent manner. We demonstrate that Lm is then rapidly 
translocated  from  the  apical  to  basolateral  side  of  IECs   JEM Vol. 208, No. 11 
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enterocytes later on in the infection (Lecuit et al., 2001;   
Pentecost et al., 2006, 2010).
We also show here that inhibition of NSF blocks the re-
lease of Lm in the lamina propria and consequently its exit 
from epithelial cells. NSF and soluble NSF attachment pro-
teins (SNAPs) are essential components of the intracellular 
membrane fusion apparatus (Jahn and Scheller, 2006). This 
suggests that Lm-containing vacuoles fuse with the baso-
lateral membrane and exocytose, releasing Lm subepitheli-
ally. There are only two in vitro studies illustrating bacterial 
exocytosis, by means of electron microscopy pictures of 
C. jejuni (Hu et al., 2008; Baker and Graham, 2010), but the 
putative role of the exocytic machinery in bacterial escape 
has not been addressed in vivo in the context of a bacterial 
infection. Lm seems to exploit the full range of Ecad recy-
cling, not only by mimicking its natural ligand Ecad, binding 
to it and inducing its internalization, but also by subverting its 
basolateral recycling in polarized epithelial cells by transcyto-
sis and exocytosis.
Lm transcytosis is strictly InlA dependent and LLO in-
dependent, whereas we have shown that the intestinal host 
response to Lm is InlA independent and strictly LLO de-
pendent (Lecuit et al., 2007). We can interpret these find-
ings as follows: at the intestinal villus level, in which Lm 
enters via InlA without inducing tissue damage, the bacte-
rium follows a furtive intravacuolar path that avoids detec-
tion by cytosolic sensors and remains undetected in the 
lamina propria, possibly because of its extracellular location 
and its ability to escape innate immune system recognition 
(Boneca et al., 2007; Gouin et al., 2010; Personnic et al., 
2010). In contrast, after translocation through M cells in an 
InlA-independent manner (Pron et al., 1998; Lecuit et al., 
2001; Corr et al., 2006; Chiba et al., 2011), Lm is phago-
cytosed by antigen-presenting cells, where LLO mediates 
vacuolar  rupture,  switching  on  the  host  response. This   
scenario illustrates how Lm has evolved mechanisms that   
allow its dissemination into the host via the intestinal lamina 
propria without inducing, at least initially, strong innate 
immune responses. This is in sharp contrast with entero-
pathogens such as Shigella flexneri that are contained at the 
intestinal level to the expense of strong and destructive in-
flammation responses.
Lm is a model microorganism that has been particularly 
instrumental for key discoveries in the fields of microbiology, 
cell biology, and immunology. By extending the cellular   
microbiology approach to tissues and by using high-resolution 
tissue-imaging techniques, we have demonstrated that the 
well-established dogma of Lm access to the cytosol for host 
tissue invasion does not apply to its early, rapid, and efficient 
crossing of the intestinal barrier. These results not only revisit 
and enrich our understanding of Lm pathogenesis, but also 
provide new clues as to how microbial pathogens breach host 
barriers. Future investigations will have to focus on the 
mechanisms of Lm breaching of the placental and blood-
brain barriers and also on how other microbial pathogens 
cross host barriers.
defense mechanism, namely mucus secretion, to target and 
cross the epithelium by transcytosis, uncovering an unsus-
pected Achilles’ heel of the innate immune system that Lm 
has evolved to take advantage of. Nevertheless, we have also 
observed that Lm interacts with intestinal GCs not expressing 
accessible Ecad, although this is far less frequent than with 
GCs that express accessible Ecad (Fig. 4 C). It has been previ-
ously reported that other internalins of Lm, such as InlB, 
InlC, and InlJ, contain mucin-binding domains able to bind 
secreted Mucin-2 (Lindén et al., 2008). However, they do 
not bind to the membrane-bound Mucin-1, suggesting that 
Lm attraction to GCs in vivo is not caused by Inl–Muc inter-
actions, but rather results from InlA–Ecad interactions. How-
ever, Inl–Muc interactions may retain Lm within the mucus 
layer in an environment close to their source, the GCs, thus 
facilitating  InlA–Ecad-mediated  bacterial  adhesion.  This  is 
further supported by the >15-fold increase of relative infec-
tion of accessible Ecad-expressing GCs compared with inlA 
interactions with GCs (Fig. 4 C).
In vitro studies have shown that bacteria can transcytose 
across cultured cell monolayers, including Campylobacter je-
juni (Grant et al., 1993; Russell and Blake, 1994; Bacon et al., 
2001; Kopecko et al., 2001; Hu et al., 2008; Watson and 
Galán, 2008), Neisseria gonorrhoeae and Neisseria meningitidis 
(Makino et al., 1991; Merz and So, 2000; Kuespert et al., 
2006; Wang et al., 2008; Sutherland et al., 2010), Streptococcus 
pneumoniae (Zhang et al., 2000; Kaetzel, 2001), and Escherichia 
coli (Burns et al., 2001; Xie et al., 2004). Yet, with the excep-
tion of bacterial sampling by M cells (see next paragraph), this 
is the first time to our knowledge that a bacterium has been 
shown to translocate across an epithelial layer by transcytosis 
in vivo, resulting in its systemic dissemination. That Lm fol-
lows a transcytosis pathway rather than its classical infection 
cycle was unexpected, as Lm is considered a prototypic intra-
cytosolic pathogen (Fig. S6 A). Yet, having evolved such a 
furtive means to cross the intestinal barrier seems perfectly in 
line with the observed rapidity of Lm transepithelial transfer, 
the absence of intraepithelial bacterial proliferation and epi-
thelial damage during the intestinal phase of listeriosis, and 
the fact that actin-based motility directionality does not pref-
erentially route Lm to the basal pole of enterocytes. But why 
doesn’t Lm escape its vacuole at the intestinal epithelium 
level to cross the intestinal epithelium? It could be that trans-
cytosis is too rapid to allow LLO-dependent Lm escape from 
its internalization vacuole. In addition, it has been recently 
shown in macrophages that LLO activity is activated by GILT 
(Singh et al., 2008). GILT is constitutively expressed in anti-
gen-presenting cells and is inducible by IFN- in other cell 
types (Arunachalam et al., 2000). Because GILT is not con-
stitutively expressed in enterocytes, it may not activate LLO 
early on in the infection, thus allowing the Lm-containing 
vacuole to be transcytosed apicobasally. Later on, as IFN- 
expression is triggered, GILT induction would lead to the 
activation of LLO, allowing Lm to be diverted from trans-
cytosis and delivered into the cytosol. In line with this   
hypothesis, intracytosolic Lm can be observed in vivo in 2274 Listeria target mucus-producing goblet cells | Nikitas et al.
raised against the extracellular domain of hEcad (Invitrogen). To detect ac-
cessible mEcad, we used ECCD-2, a specific rat mAb raised against the   
extracellular domain of mEcad (Invitrogen). We used an antibody against the 
cytoplasmic domain of Ecad (36/Ecad mouse mAb; BD) to show the associ-
ation of Lm with a membrane vacuole because internalized Ecad decorates 
the vacuolar membrane.
For Sytox staining, 1 µM Sytox green (Invitrogen) was injected into an 
intestinal ligated loop for 30 min. The tissue was then harvested, fixed, and 
processed as described above for further staining.
For immunofluorescence of cryosections, retrieved tissues were fixed 
and embedded in OCT compound at 80°C (Tissue-Tek), cut using a 
cryostat at 20°C (7-µm-thick sections), postfixed in pure ethanol, and 
labeled with the appropriate primary and secondary antibody for 1 h at room 
temperature and 2 h at room temperature, respectively. Sections were 
mounted in fluorescent mounting medium (Fluoromount).
Microscopy. Samples were imaged with an upright LSM510 two-photon 
META (Carl Zeiss) or with an LSM700 confocal microscope (Carl Zeiss) 
with a 40× water immersion objective. Image analysis was performed using 
ImageJ (National Institutes of Health), LSM 5 Image Browser (Carl Zeiss), 
and Photoshop software (Adobe). Three-dimensional reconstructions were 
performed using Imaris 5.5.3 software (Bitplane).
TEM. Infected intestinal tissues were washed in PBS and fixed in 2.5%   
glutaraldehyde–0.1 M cacodylate buffer solution overnight at 4°C. Fixed tissues 
were washed three times in cacodylate buffer and then fixed for 1 h at room 
temperature in 1% OsO4 in the same buffer. Fixed tissues were washed once 
in cacodylate buffer and twice in distilled water. After dehydration in an   
ethanol-graded series and in propylene oxide, tissues were embedded in epoxy 
resin. Specimens were cut using an ultramicrotome Reichert Ultracut S. 
60-nm sections were picked up on Formvar regular mesh grids, contrasted 
with uranyl acetate and lead citrate, and observed on a JEM 1010 (JEOL) 
under standard conditions at 60 kV.
Calculation of Lm associations with cell subtypes. Ligated loops were 
fixed 40 min p.i. and labeled with WGA and for accessible hEcad and Lm. 
The relative proportions of GCs, NGCs, and AGCs were calculated (see 
Results). The amount of Lm per cell for each cell subtype was determined, 
taking into account the accessibility of hEcad. We finally calculated the 
number of Lm per cell type relative to the respective abundance of each cell 
type and normalized to Lm associations with AGCs (Fig. 4 C).
Antibodies and fluorescent probes. The following pAbs, mAbs, and other 
fluorescent probes were used for immunolabeling of tissues: anti–hEcad clone 
HECD-1 mouse mAb (Invitrogen), anti-Ecad clone 36/Ecad mouse mAb 
(BD), anti–mEcad clone ECCD-2 rat mAb (Invitrogen), anti–ZO-1 rabbit 
pAb (Invitrogen), anti-occludin rabbit pAb (Invitrogen), anti-PARD3A (H-70) 
rabbit pAb (Santa Cruz Biotechnology, Inc.), anti–PKC (C-20) rabbit pAb 
(Santa Cruz Biotechnology, Inc.), anti-ITF (M-18) goat pAb (Santa Cruz 
Biotechnology, Inc.), anti–Mucin 2 (R-12) goat pAb (Santa Cruz Biotech-
nology, Inc.), WGA conjugated with Alexa Fluor 555, Alexa Fluor 647, or 
Alexa Fluor 488 (Invitrogen), Alexa Fluor 647 or Alexa Fluor 488 phalloidin 
(Invitrogen), Hoechst 33342 (Invitrogen), Alexa Fluor 488 or Alexa Fluor 546 
goat anti–rabbit, Alexa Fluor 488 or Alexa Fluor 546 goat anti–mouse, Alexa 
Fluor 488 goat anti–rat, donkey anti–goat-FITC, donkey anti–goat-rhodamine, 
and TUNEL (in situ cell death detection kit fluorescein; Roche).
Statistics. Values are expressed as mean ± SD. Statistical comparisons were 
made using two-way analysis of variance with Tukey adjustment for multi-
ple comparisons and timed data analysis (Olsen, 2003) or using a Student’s   
t test for single comparisons.
Online  supplemental  material.  Fig.  S1  shows  that  Ecad  accessibility 
is an intrinsic property of intestinal villus epithelium. Fig. S2 shows that 
WGAhi cells are GCs, lack apical actin cytoskeleton, and are stained for 
MATERIALS AND METHODS
Bacterial strains and culture conditions. Bacterial strains used in this 
study are Lm strain EGD (BUG 600), its isogenic deletion mutants inlA 
(BUG 947), hly (BUG 1954), and actA (BUG 2140), and Li WT (BUG 
499) and Li-expressing InlA (BUG 1489). The inocula used are shown in 
figure legends and are 1–3 × 109 per intestinal ligated loop. Bacteria were 
cultured as described previously (Disson et al., 2009).
Animals. We used transgenic mice expressing hEcad on a C57BL/6 genetic 
background (Lecuit et al., 2001). To generate mice expressing both a membrane- 
targeted Tomato protein and the humanized E16P Ecad, mT/mG mice 
were crossed with E16P KI mice (Charles River; Muzumdar et al., 2007; 
Disson et al., 2008). Animal experiments were performed according to the 
Institut Pasteur guidelines for laboratory animals’ husbandry. For intestinal 
ligated loops, 8–12-wk-old mice were fasted for 16 h before surgery.   
After mild anesthesia of mice with 2.5% (vol/vol) vaporous isoflurane (Aer-
rane; Baxter), deep anesthesia was induced with a mix of ketamine (50 mg/kg 
body weight; Imalgene 1000; Merial) and medetomidine (0.5 mg/kg body 
weight; Domitor; Orion Corporation). A laparotomy was performed, the 
small intestine was exposed, and jejunal loops of 3 cm long were prepared. 
200 µl of inoculum was injected into each loop. At the planned endpoint, 
the animal was euthanized, and intestinal loops were harvested, opened lon-
gitudinally, washed repeatedly in 37°C Dulbecco’s modified Eagle’s medium 
(Invitrogen), and fixed flat (luminal side up) in 35 × 10–mm tissue culture 
dishes (BD) containing 4% agarose (Sigma-Aldrich). For IL-33 administra-
tion, 400 ng of recombinant mouse IL-33 (R&D Systems) in PBS were admin-
istered daily for 3 d intraperitoneally. Intestinal ligated loops were performed 
24 h later after the last injection. Control animals received PBS only.
All the procedures were in agreement with the guidelines of the European 
Commission for the handling of laboratory animals, directive 86/609/EEC 
(http://ec.europa.eu/environment/chemicals/lab_animals/home_en.htm) and 
were approved by the Animal Care and Use Committee of the Institut Pasteur.
Enumeration of CFUs. For CFU enumeration, the organs were retrieved 
and grounded, and serial dilutions were plated on BHI (brain heart infusion) 
agar plates as previously described (Disson et al., 2009).
Pharmacological treatments. For microtubule depolymerization and in-
hibition of polymerization, 10 µg/ml nocodazole and 10 µg/ml colchicine 
(Sigma-Aldrich) were used per ligated loop (Mostov et al., 1984; Ameen   
et al., 2003; Wang et al., 2008). Loops were initially infected for 10 min and, 
subsequently, nocodazole or colchicine was added and kept along the infec-
tion (50 min). For exocytosis inhibition, we used 20 µg/ml of the recombi-
nant NSF peptide TAT-NSF700 (AnaSpec). This peptide has been described 
to be the most potent peptide to enter cells and inhibit NSF-mediated 
ATPase activity and SNARE complex disassembly. TAT-NSF700scr (AnaSpec) 
is a control peptide that does not inhibit NSF activity (Matsushita et al., 2003, 
2005). The TAT-NSF700 peptide conjugated to cyanin 3 (RD-Biotech) 
was used to verify the entry of the peptide in cells.
Tissue  labeling  for  immunofluorescence. Tissues were fixed in 4% 
paraformaldehyde (Electron Microscopy Sciences) in PBS for 1 h at room 
temperature under agitation and either stained directly (whole mount) or 
embedded  in  4%  low-melting-point  agarose  (Sigma-Aldrich)  for  100– 
250-µm-thick vibratome sections (Micro HM 650V; Thermo Fisher Scientific;   
Appleton et al., 2009). Sections were stained in a similar manner to whole 
mount tissue but mounted in fluorescent mounting medium (Fluoromount; 
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